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Vasectomy, cigarette smoking, and age at first sexual intercourse as risk
factors for prostate cancer in middle-aged men
G.D. Honda', L. Bernstein2, R.K. Ross2, S. Greenland3, V. Gerkins2 & B.E. Henderson2
1Tulane University, School of Medicine, New Orleans, Louisiana; 2University of Southern California School of Medicine, Los
Angeles California; 3 University of California, Los Angeles, School of Public Health, Los Angeles, California, USA.
Summary A population-based case-control study was conducted in men aged 60 or less to assess the risk of
prostate cancer associated with vasectomy and other factors. Data were obtained from 216 case-control pairs
by telephone interviews; this number represented 55% of all eligible cases.
The matched pairs relative risk (RR) for vasectomy in ever married men was 1.4 with a 95% confidence
interval (CI) of 0.9-2.3. There was a positive association between the number of years since vasectomy and
prostate cancer risk (1-sided P=0.01). Early age at first sexual intercourse was associated with increased
prostate cancer risk (age < 17 vs. 21 +, RR = 2.3, 95% CI = 1.3, 4.0) but there were no consistent associations
with number of sexual partners or frequency of sexual intercourse. Cigarette smoking was also associated with
increased risk of prostate cancer (RR= 1.9, 95% CI = 1.2, 3.0) and there was a positive dose-response
relationship with years of smoking (1-sided P=0.001). We discuss the possible implication of the low response
rate on each of these findings.
To determine whether the association with vasectomy might have a hormonal basis, we compared levels of
testosterone (T) and testosterone binding globulin-binding capacity (TeBG-bc) in 33 of the vasectomized
control men with levels in 33 non-vasectomized controls of the same age, weight and height. T levels were
higher in vasectomized than in non-vasectomized controls (1-sided P=0.06). The ratio of T to TeBG-bc (an
index of bioavailable T) was 13.5% higher in vasectomized men (1-sided P=0.03).
It has been hypothesized that a vasectomy may lower the
risk of prostate cancer (Sheth et al., 1982). This hypothesis is
based in part on the observation that vasectomized rats have
decreased prostate function and size (Kinson & Layberry,
1975; Pierrepoint & Davies, 1973). There is also evidence of
decreased prostatic activity following vasectomy in man
(Naik et al., 1980). On the other hand, there are studies
which indicate that vasectomy may result in increased serum
testosterone levels (Johnsonbaugh et al., 1975; Purvis et al.,
1976; Smith et al., 1979), which have been hypothesized to
increase prostate cancer risk (Ross et al., 1983). The
epidemiologic data are equivocal (Ross et al., 1983; Mandel,
1981).
We conducted a prostate cancer case-control study in Los
Angeles County to further test this hypothesis. Data were
ascertained on each subject's surgical history, use of
cigarettes and alcohol, and marital, fertility and sexual
history. In order to provide further information on the
association of vasectomy and circulating testosterone levels,
we compared testosterone (T) and testosterone binding
globulin-binding capacity (TeBG-bc) in 33 of the control
men, vasectomized from 3 to 36 years earlier, and in 33
other controls of the same age, race, weight and height, who
had not had a vasectomy.
Patients and methods
Cases were men with histologically diagnosed adeno-
carcinoma of the prostate identified by the Cancer
Surveillance Program (CSP), a population-based tumour
registry covering the more than 8 million residents of Los
Angeles County, California. Operational details of the
registry have been previously described (Mack, 1977). Cases
were retrospectively identified from January, 1979 to
February, 1982, inclusively. Cases were restricted to white
non-Spanish-surnamed males with no previous cancer
history. Since vasectomies first became popular as a method
of birth control among middle-aged men during the 1960s,
the expected vasectomy prevalence among men over age 60
is low. Thus, the case group was restricted to men aged 60
or less. Blacks were not included in the case group because
male sterilization is less common among US blacks than US
whites (Bachrach & Mosher, 1984).
A total of 402 eligible cases were identified by the CSP
and 221 of these (55%) were interviewed by telephone using
a highly structured format with explicit probes. Interviews
were not obtained with cases for the following reasons:
physician refused permission to contact the case (n= 50),
case refused to participate (n=22), case died (n=76), case
could not be located (n=24), or hospital did not permit case
to be contacted (n=9).
For each interviewed case, a neighbourhood control was
sought who was white, non-Spanish surnamed, with no
previous cancer diagnosis, and whose date of birth was
within five years of the case's date of birth. Each neighbour-
hood control was systematically located by contacting resi-
dential units along a pre-determined walking pattern near
the case's residence at the time of diagnosis. The matched
control was the first eligible control in the walking pattern
who agreed to be interviewed. For 76% of the matches, this
was the first eligible man identified; for 19% of the matches
the second eligible man was interviewed. Overall 71 potential
controls refused to participate for a control refusal rate
(refusals/(refusals+interviews)) of 25%. The median number
of living units contacted prior to that of the interviewed
control was 11. The exposure history of controls was pre-
sumed to end at the diagnosis date of the matched case.
All interviews were conducted by one male interviewer
(GH). During the interview, subjects were asked whether
they had been vasectomized. Of the 45 control men who
reported having had a vasectomy, 33 who had no health
problems which might affect the results of this study, agreed
to participate in the serological study. To minimize the
potential confounding effects of age and obesity on T and
TeBG-bc levels, we individually matched 33 healthy non-
vasectomized males from the control pool to the eligible
vesectomized males by year of birth (within 5 years), weight
(within 4.5 kg), and height (within 5cm). In addition, the
vasectomized and non-vasectomized control subjects were
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matched within one social class grouping (based on the
average education and income levels of the census tracts in
which they resided) (Henderson et al., 1975).
Fifteen millilitre samples of blood were drawn by veni-
puncture between 8 a.m. and noon in the subjects' homes by
VG. The serum was stored at -20°C for time periods
ranging from 1 to 4 months. Aliquots were delivered on dry
ice to Endocrine Sciences Laboratories, Tarzana, CA, for
determination of T (Furuyama et al., 1970) and TeBG-bc
levels (Nankin et al., 1975). The identity of the specimens
was not known to the processing laboratory. The only
identifier was a coded number unique for each submission of
a specimen.
We maintained the matched pairs design in the statistical
analysis of questionnaire data. For dichotomous variables we
used McNemar's chi-quare test and computed point esti-
mates and exact 95% confidence limits (Breslow & Day,
1980). For continuous variables and those with multiple
levels, we used conditional logistic regression methods to
estimate the relative risk (RR) (Breslow & Day, 1980). For
ordinal variables, a trend test was used to determine whether
there was a dose-related increase or decrease in risk in the
matched data.
Statistical analyses for the serological data were performed
using paired t-tests, and repeated measures analyses of
covariance to assess the significance of differences in means
(Sokal & Rohlf, 1981). In addition to T and TeBG-bc, the
ratio T/TeBG-bc was evaluated. This ratio is useful as an
index of free T as it provides a theoretical value of T at a
fixed TeBG-bc level (1.Omcg of DHT bounddl-1) (Udry
et al., 1985). Quetelet's index (1000 x weight/height2) was
used as a measure of obesity. T, TeBG-bc and T/TeBG-bc
followed lognormal (base 10) distributions and logarithmic
(base 10) values of these variables were used in all statistical
analyses. Geometric mean values are presented for serologic
data. The analyses of covariance assumed a linear relationship
between the covariate(s) and log hormone measures.
Results
Questionnaire data
Data on 216 case-control pairs were used in the analysis.
Five unmatched interviewed cases were omitted. Forty-six
percent of the controls were matched within two years of the
case's date of birth and 80% were matched within four
years. The age distribution for cases used in the analysis was
as follows: <age 53, n=32; age 53-57, n=67; and age 58-
60, n=117.
Neither marital status nor age at first marriage were
associated with prostate cancer occurrence. Five percent of
both cases and controls had never been married.
Vasectomized men had slightly higher risk of prostate
cancer. Thirty-five percent of the married cases and 23% of
the married controls had been vasectomized (RR= 1.4,
CI = 0.9-2.3). There was a positive relationship between
prostate cancer risk and the number of years since
vasectomy (trend test, 1-sided P=0.01). Compared to non-
vasectomized men, men who had been vasectomized 30 or
more years earlier had a RR of 4.4 for prostate cancer
(Table I).
Early age at first sexual intercourse also was associated
with an increased prostate cancer risk. The relative risk (age
< 17 vs. 21 +) was 2.3 (CI= 1.3-4.0). Number of sexual
partners was not consistently associated with risk of prostate
cancer (Table II). Having sexual intercourse either in-
frequently (<1/week) or frequently (4+/week) three years
prior to diagnosis was associated with increased prostate
cancer risk when compared to intermediate levels of fre-
quency. To determine whether the high risk associated with
infrequent sexual intercourse (<1 week) was due to more
advanced disease in these cases, we evaluated risk by disease
Table I Matched relative risks (RR) for marital status, age at first
marriage, and years from vasectomy
No. No.
Variable casesa controls? RR 95% CI pb
Marital status
Ever married 205 206 l.0*C
Never married 11 10 1.1 0.4,3.3
Age at first marriage
< 23 83 70 1.0*C
23-24 33 36 0.8 0.4,1.4
25-27 40 45 0.7 0.4,1.3
28+ 40 45 0.7 0.4,1.3 0.10
Years from vasectomy
0 (none) 138 151 1.0*C
1-9 8 11 0.7 0.3,1.9
10-19 18 19 1.0 0.5,2.0
20-29 24 13 2.2 1.0,4.8
30+ 8 2 4.4 0.9,21.0 0.01
aNumbers do not always total 216 due to missing values; bl-sided,
test for trend; cAnalyses restricted to case-control pairs in which
both men had been married.
*Referent category.
stage. This bimodal effect was apparent across all disease
stage strata. Men with a venereal disease history were at
increased risk, although the prevalence among the controls
was low (gonorrhoea 11.6% and syphilis 0.5%) and the
results were statistically imprecise (Table II).
Cigarette smoking was associated with moderately in-
creased prostate cancer risk. The RR (ever vs. never smoked)
was 1.9 (CI=1.2-3.0). There was a positive relationship
between prostate cancer risk and smoking duration (trend
test, 1-sided P=0.001). Men who had smoked at least 40
years had 2.6 times the risk of men who had never smoked
(Table III).
Men who reported previous prostate problems had
strongly increased prostate cancer risk. Most of these
prostate conditions were reported to have occurred at least
10 years prior to the date of prostate cancer diagnosis. The
prevalence of these problems among the cases and the
associated relative risks were as follows: prostatitis (17%,
Table II Matched relative risks (RR) for other sexual activity
variables
No. No.
Variable cases? controls? RR 95% CI pb
Age at first intercourse
< 17 83 54 2.3 1.3,4.0
17-18 51 59 1.3 0.7,2.3
19-20 44 45 1.5 0.8,2.8
21+ 33 53 1.0* 0.002
Number of sexual partners
<3 39 42 1.0*
3-7 52 53 1.1 0.6,1.9
8-20 52 48 1.2 0.6,2.1
21+ 43 43 1.1 0.6,2.1 0.36
Frequency of sexual intercourse/week (3 years pre-diagnosis)
< 1 48 22 3.6 1.8,7.0c
1 54 65 1.3 0.8,2.3
2 50 75 1.0*
3 36 32 1.9 1.0,3.7
4+ 20 14 2.5 1.1,5.9
Venereal diseased
Gonorrhoea 33 25 1.4 0.8,2.6
Syphilis 6 1 6.0 0.7,276.0
Either 35 25 1.5 0.8,2.7
aNumbers do not always add to 216 due to missing values; bl-
sided test for trend; c2-sided P=0.0002; dReference groups differ for
each analysis.
*Referent category.
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Table III Matched relative risks (RR) for cigarette smoking, pros-
tate problems, and family history of prostate cancer
No. No.
Variable cases? controls? RR 95% CI pb
Years of smoking
0 44 69 1.0*
1-9 10 1 1 1.7 0.6,4.4
10-19 22 25 1.4 0.7,2.6
20-39 90 78 1.9 1.1,3.1
40+ 49 32 2.6 1.4,4.9 0.001
Prostate problem
Prostatitis 39 18 2.2 1.2,4.3
Enlarged prostate 56 19 3.6 2.0,7.1
Prostate 'surgery' 14 7 2.0 0.8,5.9
Prostate cancer history in:
Father 17 6 2.8 1.1,8.8
Brother 4 0
Either father
or brother 21 6 3.5 1.4,10.6
aNumbers do not always total 216 due to missing values; bl-sided
test for trend.
*Referent category.
RR=2.2), enlarged prostate (25%, RR=3.6), and prostate
'surgery' (9%, RR = 2.0) (Table III). Reported prostate
problems were not verified against medical records.
There was also a strong association between prostate
cancer and having a father or brother with prostate cancer
(RR= 3.5, CI= 1.2-10.6) (Table III). No similar association
with non-prostatic cancer among fathers and brothers was
observed.
The average alcohol intake (g day 1) was calculated from
the reported intake of beer, wine, and liquor (based on 10,
13, and 20 g alcohol per drink, respectively). No consistent
association was observed with increasing alcohol
consumption. There were also no consistent associations
between prostate cancer risk and measures of height (H),
weight (W) or adjusted weight (W/H, W/H2, or W/H3).
Adjustment of vasectomy status and cigarette smoking
history for each other or for the demographic variables,
marital factors, fertility factors, and sexual history factors
examined in this study, using conditional logistic regression
methods, did not substantially alter the associations with
prostate cancer. The association of early age at first sexual
intercourse (age < 17 vs. later) with prostate cancer risk was
reduced from RR= 1.9 to RR= 1.5, after controlling
simultaneously for number of years since vasectomy and
cigarette smoking duration.
Hormone assay results
Characteristics of vasectomized and non-vasectomized
control men contributing serum samples are compared in
Table IV. Non-vasectomized men were, on average, 1.4 years
older than vasectomized men (2-sided P<0.0001). The two
groups were closely matched on W, H and Quetelet's index.
There were no important differences in the distribution of
vasectomized and non-vasectomized men by the time of day
that blood samples were drawn. The two groups were
comparable in terms of sexual activity factors. More non-
vasectomized men were current smokers (33% vs. 21% of
vasectomized men).
Results of the serum assays are presented in Table V. The
adjusted geometric mean T level (adjusted for exact time of
sample collection) was 6.7% higher (1-sided P=0.06) and
the adjusted geometric mean T/TeBG-bc ratio was 13.5%
higher (1-sided P=0.03) in vasectomized than in non-
vasectomized men. Vasectomized men had adjusted
geometric mean TeBG-bc levels that were 4.5% lower than
those of the control group (1-sided P=0.44). There were
only modest associations between years since vasectomy and
Table IV Characteristics of vasectomized and non-vasectomized
men. Mean + standard deviation presented unless otherwise noted
Study status
Variable Vasectomy Non-vasectomy
Age at sampling 59.7+4.5 61.1 +3.9
Weight (kg) 83.4+8.1 82.7 + 18.8
Height (cm) 179.2+6.2 179.5 +2.7
Quetelet's index 2.6 +0.1 2.5 +0.1
Years since vasectomy 17.7 + 8.3 -
Ever cigarette smoker
Current (%) 21 33
Former (%) 40 43
Total years smoked 27.6+14.9 30.5 + 16.5
Time of sample collection (a.m.)
8:00-9:59 55 64
10:00-11:59 45 36
Mean 9:47 9:25
Sexual factors
Age at first intercourse (%)
< 17 21.2 33.3
17-18 33.3 21.2
> 18 45.5 45.5
Median lifetime
number of sexual partners 9 6
Weekly frequency of sexual
intercourse (in 1979) 2.1+ 1.3 1.9+1.3
Table V Geometric mean serum levels of testosterone (T), testo-
sterone binding globulin-binding capacity (TeBG-bc), and ratio of T
to TeBG-bc in vasectomized and non-vasectomized men
Study status
1-sided
Serum level Vasectomy Non-vasectomy P-valuea
T (ngdl-')
Unadjusted 495.0 471.7
(2.70+0.14) (2.67+0.18)
Adjustedb 499.1 467.8 0.056
TeBG-bc (ugdl 1)
Unadjusted 1.05 1.11
(0.020+0.15) (0.044+0.13)
Adjustedb 1.05 1.10 0.444
T/TeBG-bc
Unadjusted 473.2 426.1
(2.68+0.13) (2.63+0.12)
Adjustedb 478.5 421.4 0.029
aBased on repeated measures analysis of covariance F test,
adjusting for age when blood was drawn and time of day that blood
was drawn (using minutes elapsed since 8 a.m.); bAdjusted to a
mean time of blood drawing of 96.7 min past 8 a.m. and to 59.9
years of age.
hormone levels in the vasectomy group and between age and
hormone levels overall. Adjustment for smoking status did
not alter these results.
Discussion
The major findings of this study are the moderately strong
relationships between prostate cancer risk and cigarette
smoking duration, first intercourse before age 17 and, for
married men, interval since vasectomy. Family history of
prostate cancer and past prostatic diseases are also strong
predictors of risk, but in the absence of medical record
validation, we cannot eliminate the possibility of recall bias
for these two findings. Previous case-control studies of the
relationship between benign prostatic hypertrophy and
prostate cancer have produced conflicting results (Armenian
et al., 1974; Greenwald et al., 1974). However, the familial
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association of prostate cancer mortality using the virtually
complete records of the Church of the Latter Day Saints
provides support for the familial risk detected here (Woolf,
1960).
The growth and development of the prostate is under the
control of testosterone and its metabolite dihydro-
testosterone, and there is considerable evidence supporting a
hormonal etiology for prostate cancer (Noble, 1982;
Ghanadian et al., 1978; Ahluwalia et al., 1981; Drafta et al.,
1982; Ross et al., 1986). Our data on hormone levels in
vasectomized and non-vasectomized men provide limited
support that the observed effect of vasectomy may have a
hormonal basis. While we find no major differences in either
T or TeBG-bc in vasectomized compared to non-
vasectomized men, when measured many years after the
procedure, our data do suggest that vasectomized men have
higher levels of biologically available T.
A number of prospective studies have examined the effect
of vasectomy on hormonal status, but the results are
equivocal; and generally, they are based on small numbers of
study subjects and have examined subjects within a short
time (no more than 2 years) after vasectomy. Several of these
studies reported no changes in hormonal status following a
vasectomy (Goebelsmann et al., 1979; Alexander et al., 1980;
de la Torre et al., 1983). Others suggested that serum T
levels may increase slightly after vasectomy (Johnsonbaugh
et al., 1975; Purvis et al., 1976). One study, with the longest
follow-up time (3 years) and largest sample, reported a
statistically significant increase in the mean serum T levels of
vasectomized men (Smith et al., 1979). Two case-control
studies evaluated plasma T levels in non-vasectomized men
and in men vasectomized from 1 to 5 years earlier (Varma et
al., 1975; Skegg et al., 1976). Neither found statistically
significant differences in T levels. In one of these studies, the
number of non-vasectomized men used for comparison was
small (n = 16) and may not have been adequate to demon-
strate a difference (Varma et al., 1975). The second study
compared 188 vasectomized men with 100 men scheduled for
a vasectomy and found mean T levels that were about 10%
higher in the vasectomy group (Skegg et al., 1976). None of
these studies examined TeBG-bc levels or indices of free T.
While the small differences observed in our study could be
an effect of the surgical procedure itself (Johnsonbaugh et
al., 1975; Purvis et al., 1976; Smith et al., 1979; Gupta et al.,
1975), other explanations seem equally plausible. One
possible explanation is that the decision to have a vasectomy
is closely related to sexual practices (i.e., men with high
levels of sexual activity choose vasectomy as a form of birth
control more frequently than sexually inactive men). In turn,
heightened sexual activity may be related to increased
circulating bioavailable androgens (Tsitouras et al., 1982),
which may be the more immediate cause of prostate cancer
development.
Cigarette smoking has not been associated with increased
risk of prostate cancer in most previous epidemiologic
studies (Hammond, 1966; Doll & Peto, 1976; Wynder et al.,
1971; Armenian et al., 1975; Jackson et al., 1980). Although
the majority of these studies were hospital-based case-control
studies and used controls who were not screened for diseases
potentially associated with smoking, most cohort studies
which have examined this relationship also have been
negative. Because of the largely negative results from
previous studies, information collected on smoking habits in
the present study was related to duration only. No data on
number of cigarettes smoked daily were available.
Nonetheless, the smoking association with prostate cancer
observed here also could have a hormonal basis. Cigarette
smoking has been shown to be associated with high circu-
lating testosterone levels in middle-aged men (Dai et al.,
1981; Deslypere & Vermeulen, 1984) although it is unclear
whether this is a cause and effect relationship. One
hypothesis to explain both an association between smoking
and prostate cancer that is limited to younger men and a
non-causal association between smoking and testosterone
levels, is that socio-cultural determinants of cigarette
smoking in the US are age-related. In younger cohorts, in
which the overall prevalence of smoking is low, regular use
of cigarettes may be more closely linked with risk-taking
tendencies and, perhaps, elevated circulating testosterone
levels.
The increased prostate cancer risk associated with early
age at first intercourse in this study has been observed by
others (Mishina et al., 1985). Others also have found
evidence that additional factors related to increased sexual
activity (frequency of intercourse, number of sexual partners,
history of venereal disease) increase prostate cancer risk
(Steele et al., 1971; Krain, 1974; Heshmat et al., 1975). In
the present study venereal disease was associated with in-
creased risk, but the association with frequency of
intercourse was complex. Findings such as these have sug-
gested the possibility that prostate cancer may be caused by
transmission of an infectious agent through sexual activity.
However, in a cohort study of cancer mortality in Catholic
priests in Los Angeles we found a small, but statistically
non-significant, excess of prostate cancer deaths (Ross et al.,
1981). The absence of a marked deficit of prostate cancer
mortality among such men is evidence against sexual trans-
mission of the disease. An alternative explanation is that
early age at first intercourse is indicative of increased sexual
activity or higher 'sex drive' among the cases and is another
indirect measure of circulating androgen levels.
We conclude that it is possible that the observed risk
factors of vasectomy, cigarette smoking, and early age at
first intercourse could all be explained by a single aetiologic
hypothesis related to high circulating testosterone. Further
study is needed to verify these associations and, if real,
their physiological basis. Further study is also needed
to determine whether the higher T/TeBG-bc ratio in
vasectomized men observed in our study is pre-existing (as
might occur if sexual practices are correlates of both
circulating T levels and of the choice of vasectomy as an
elective birth control method), or whether the procedure
itself results in higher bioavailable T levels.
Only 55% of eligible cases were interviewed in this study,
raising important questions about the representativeness of
the interviewed cases to all eligible cases in terms of the
variables evaluated. The high rate of deaths (19% of all
eligible cases) is of particular concern, and is related, in part,
to our decision to interview retrospectively identified cases.
As expected, interviewed cases tended to have less advanced
disease at diagnosis, but were similar to non-interviewed
cases on other demographic variables routinely collected by
the CSP, including religion, occupation, median income of
the census tract of residence, and mean age at diagnosis.
However, these similarities offer no great reassurance that
some of the factors being investigated might have influenced
outcome (or other losses) rather than disease development. If
anything, we might expect survivors to be underrepresented
by smokers given the myriad of health problems associated
with smoking. In addition, since prostate cancer growth is
often testosterone dependent, if the risk factors identified in
this study are indices of testosterone production as hy-
pothesized above, we again would expect that survivors
might be underrepresented by individuals 'positive' for these
variables. To the extent that any of the losses in this study
were social class related, our use of neighbourhood controls
with matched analyses should have minimized bias.
A second methodologic concern in interpreting the results
of this study is the validity of information collected by a
telephone interview, particularly for variables dealing with
sexual activity, contraceptive practices and other 'sensitive'
areas. Vasectomies have become a common method of male
sterilization and there appears to be no social stigma as-
sociated with the procedure (Uehling & Wear, 1972). Based
on interviews, there is nearly 100% agreement between
reported vasectomy status and medical records (Massey et
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al., 1985), but we know of no comparable data based on
telephone interviews. Only 3 questions dealing specifically
with sexual activity were asked in this study and these were
placed at the end of the interview, to allow good rapport to
develop between the interviewer and the participant.
Although every participant provided an estimate of age at
first intercourse, 10% of cases and 5% of controls either
refused or could not estimate their number of sexual
partners. One could speculate about possible non-random
misclassification of responses (e.g. cases providing more
accurate responses due to personal interest in the study or
controls choosing more conservative, 'safer' responses
because of lingering concerns about how the information
would be used), but we believe it more likely that misclassifi-
cation occurred to a comparable degree among cases and
controls, resulting in underestimations of any true as-
sociations.
Supported by Grant CA17054, from the National Cancer Institute,
National Institutes of Health, Bethesda, MD.
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